姜黃素對(duì)丙烯酰胺導(dǎo)致人神經(jīng)母細(xì)胞瘤細(xì)胞凋亡的抑制作用.pdf

1、Huazhong University of Science and TechnologyMaster DissertationThe inhibition effects of curcumin on acrylamide-inducedapoptosis in SH-SY5Y cellsCandidate: Xu WuMajor: Public HealthSupervisor: Associate Prof.Hong YanDat

2、e: May, 2017目錄 目錄全文縮寫詞..............................................................................................................................1摘要.....................................................................

3、.......................................................................2前言............................................................................................................................................6材料與方法

4、............................................................................................................................11結(jié)果............................................................................................

5、..............................................161 CUR 減輕 ACR 對(duì) SH-SY5Y 細(xì)胞形態(tài)和細(xì)胞存活率的影響..........................162 CUR 對(duì) ACR 導(dǎo)致 SH-SY5Y 細(xì)胞內(nèi)氧化應(yīng)激的影響..................................193 CUR 對(duì) ACR 導(dǎo)致 SH-SY5Y 細(xì)胞凋亡的影響.........

6、.....................................214 CUR 抑制 ACR 對(duì) SH-SY5Y 細(xì)胞 NF-κB 的激活.........................................235 NF-κB 在 ACR 誘導(dǎo) SH-SY5Y 細(xì)胞凋亡中的作用.......................................25討論...........................

7、...............................................................................................................28結(jié)論.........................................................................................................

8、.................................32參考文獻(xiàn)................................................................................................................................ 33綜述................................................

9、..........................................................................................36附錄..............................................................................................................................